...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of women’s health >Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient
【24h】

Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient

机译：人类乳头瘤病毒疫苗接种和PAP涂抹在美国的年轻女性中的吸收：提供者和患者的作用

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: It has been reported that Pap smear use is higher among U.S. women who received the human papillomavirus (HPV) vaccine than unvaccinated women. This study assessed the role of provider and patient in the difference of Pap smear use by vaccination status. Methods: We conducted a cross-sectional study of 5416 young women (21-30 years of age) with detailed information on Pap smear use and HPV vaccination status from the National Health Interview Survey (NHIS) 2013-2015. Vaccinated women received at least one dose of HPV vaccine. Main outcomes included Pap smear in the past year, provider's recommendation for Pap smear, and patient-initiated Pap smear. Results: The prevalence of Pap smear in the past year was much higher among vaccinated women than unvaccinated women (67.5% vs. 52.8%, p<0.001). Compared with unvaccinated women, vaccinated women were more likely to receive a provider's recommendation for Pap testing (60.8% vs. 50.8%, p<0.001), to obtain Pap testing after receiving a provider's recommendation (75.1% vs. 67.9%, p=0.004), and to initiate Pap testing themselves (57.7% vs. 38.2%, p<0.001). However, among women who visited an obstetrician/gynecologist (OB/GYN) in the past year, the positive association between HPV vaccination and Pap smear recommendation and uptake vanished. Conclusions: Unvaccinated women who have not visited an OB/GYN in the past year are less likely to receive a recommendation for Pap testing from their providers or to initiate Pap testing themselves without a provider's recommendation. They should be encouraged to visit an OB/GYN provider for cervical cancer screening.
机译：背景：据报道，在接受人乳头瘤病毒（HPV）疫苗的美国女性中，PAP涂片用途比未接种疫苗的妇女更高。本研究评估了提供者和患者在PAP涂片用途疫苗用途的作用。方法：我们对5416名年轻女性（年龄21至30岁）进行了横断面研究，详细信息来自国家卫生访谈调查（NHIS）2013-2015的PAP涂片使用和HPV疫苗接种状态。疫苗接种的女性至少收到一剂HPV疫苗。主要结果包括过去一年的PAP涂片，提供商对PAP涂片的建议和患者发起的PAP涂片。结果：疫苗的女性在过去一年中的PAP涂片的患病率远高于未接种的妇女（67.5％vs.52.8％，P <0.001）。与未接种的妇女相比，接种疫苗的妇女更有可能获得提供者的PAP测试推荐（60.8％与50.8％，P <0.001），以获得提供商的建议后获得PAP测试（75.1％与67.9％，P = 0.004），并启动PAP测试本身（57.7％对38.2％，P <0.001）。然而，在过去一年访问过​​产科/妇科医生（OB / GYN）的妇女中，HPV疫苗接种和PAP涂抹推荐和吸收之间的积极关系消失了。结论：过去一年没有访问过OB / GYN的未接触妇女不太可能收到来自其提供商的PAP测试的建议，或者在没有提供者的建议的情况下启动PAP测试。应该鼓励他们访问宫颈癌筛查的OB / Gyn提供者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号